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Abstract. The increase in population and the high maternity death rate has caused the 
government to mitigate birth rate by providing KB (Family Planning), using contraceptive 
devices; one of them is progesterone and estrogen hormone injection, done by 
intramuscularly method in fertility-aged women. Its side-effect isthat it can influence 
menstruation irregularity. The objective of the research was to find out menstruation pattern 
of the users of progestin and combination injections at Kelurahan Sendang Sari and 
Kelurahan Dadi Mulyo, Kisaran Barat Sub-district, where the research was done. The 
population was 348 people at the two villages, and 76 of them were used as the samples, 
taken by using accidental sampling technique. The result of the research showed that 32 
respondents (84.2%) were not in abnormal category in their menstruation pattern, using 
progestin injection, and 29 respondents (76.3%) were in abnormal category in the 
menstruation pattern, using combination injection. It is recommended that KB counselors 
provide counseling about the mechanism of the work of injection contraception which 
causes side-effect of menstruation irregularity. 
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1. Introduction 
Indonesia is a developing country with an increasing number of population growth as well as 
high maternal mortality and reproductive health needs. The Indonesian government through the 
National Population and Family Planning Agency (BKKBN) will emphasize the number of 
child births, welfare of mothers and children, distance and ideal age for childbirth, regulate 
pregnancy in the management of family planning programs by using contraception to create a 
healthy family and quality (RI Ministry of Health, 2014). 
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Injectable contraception is a hormonal contraception that is intramuscularly injected as an effort 
to prevent pregnancy in the form of the hormone progesterone and estrogen in women of 
childbearing age. The use of injectable contraception affects the hypothalamus and pituitary. 
There are 2 types of injection contraception that are now widely used, namely combination 
injections (1 month) and progestin injections (3 months) (Mulyani, 2013: 87). 
Combination injections (I months) contain 25 mg of Depo Medroxyprogesterone Acetate and 
Estradiol 5 mg. 1-month injection contraception is very effective during the first year of use but 
has a disadvantage of changing menstrual patterns such as irregular, spotting or bulging 
bleeding, intermittent bleeding for up to ten days. Then, progestin injection contraception (3 
months) is a contraceptive method that is given intramuscularly every three months. This type 
of contraception is DMPA (Depot medroxy progestin acetate) which is given in a dose of 150 
ml / gr intramuscularly. Effective injection of progestin is very high, but the injection is carried 
out regularly in accordance with the schedule specified. However, the disadvantages are 
menstrual disorders such as amenorrhea, spooting, metroragia, menoragia (Mulyani, 2013: 94). 
The mechanism of injection contraception works is inhibiting ovulation by suppressing the 
expenditure of follicle stimulating hormone (FSH) and Luteneizing hormone (LH), thickening 
the cervical mucus so that it inhibits sperm penetration through the uterine cervix, inhibits 
implantation of the ovum in the endometrium (Pinem, 2009). 
Injectable contraception is a hormonal contraception that is intramuscularly injected as an effort 
to prevent pregnancy in the form of the hormone progesterone and estrogen in women of 
childbearing age. The use of injectable contraception affects the hypothalamus and pituitary. 
(Mulyani, 2013: 87). 
The types of injection contraception, namely progestin injections, are contraceptive methods 
that are given intramuscularly every three months. The working mechanism of a progestin 
injection contraception is to prevent ovulation by thickening cervical mucus to prevent sperm 
from titrating or preventing the implantation of fertilized eggs (IFPA, 2008). Lack of 
contraception is a menstrual disorder such as a normal menstrual pattern that becomes abnormal 
which changes to amenorrhea, which is not menstruating every month for 3 consecutive months. 
Spoting, which is bleeding spots outside of menstruation, metroragia, which is excessive 
bleeding outside the menstrual period, menoragia, namely excessive menstruation, weight gain, 
dizziness and headaches, pimples on the body or face can be accompanied by infection if long-
term use, increases risk esteoporosis (Melani, 2010). 
Combination contraception is a method that is given every month by intramuscular injection 
containing 25 mg of Depo Medroxyprogesterone Acetate and 5 grams of Estradiol Sipionate. 
The mechanism of action of contraception in the mechanism of action between combined 
injection contraception with the same oral ie preventing ovulation causes suppression of 
secretion of follicle stimulating hormone (FSH) by increasing Lutenizing Hormone (LH) 
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(WHO, 2004). Losses Combination contraception (1 month), namely (1) changes in menstrual 
patterns such as irregular, spot or spoting bleeding, intermittent bleeding for up to ten days; 
Menstruation is periodic bleeding from the uterus which starts around 14 days after ovulation 
periodically due to the release of uterine endometrial relaxation (Bobak, 2004). According to 
Pritchard (1991), regular menstrual patterns include menstrual cycles that vary from 28 days to 
30 days, the duration of bleeding between 4-6 days but 2-8 days is still considered 
physiological, menstrual blood counts of 25-60 ml. As for Monawa et al (2016), namely the 
average menstrual cycle is 28 days and the cycle can range from 21-35 days in adults. 
According to Kusmiran (2011), the factors that influence irregular menstruation: 
(1) Hormone factors that affect menstruation in a woman, Follicle Stimulant Hormone (FSH) 
released by the pituitary, estrogen produced by the ovary, Luteinizing Hormone (LH) produced 
by the pituitary, as well as progesterone produced by the ovary. 
(2) Enzyme Factors Hydrolysis contained in the endometrium damages cells that play a role in 
protein synthesis, which disrupts metabolism resulting in endometrial regression and bleeding. 
(3) The vesicular factor in the proliferation phase is the formation of a vascular system in the 
functional layer of the endometrium. The growth of the endometrium also follows arteries, 
veins, and the relationship between the two with endometrial regulation, arises statically in 
venena and the channels that connect with the arteries, and finally ovulation and bleeding with 
hermatoma formation, both from arteries and veins . 
(4) Prostaglandin factors, namely (endometrium containing prostagladin E2 and F3 in the 
presence of endometrial disintegration, prostagladin is released and causes contraction of the 
myometrium as a factor to limit menstrual bleeding. 
(5) Body weight affects menstrual function. According to Rejeki (2014), nutritional status can 
have an influence on menstrual patterns where obesity is also accompanied by anovulatory 
cycles due to an increase in tonic estrogen levels which can cause disruption of irregular 
menstrual cycles. Body Mass Index (BMI) or Body Mass Index (BMI) is a simple tool or way to 
monitor the nutritional status of adults, especially those associated with underweight and 
overweight. 
(6) Physical activity, which is a moderate and severe level of activity can limit menstrual 
function. Heavy physical activity stimulates the inhibition of Gonadotropin Releasing Hormone 
(GNRH) and Gonotropin activity thereby reducing levels of serum estrogen. 
(7) Stress causes systemic changes in the body, especially the nervous system in the 
hypothalamus through changes in prolactin or endogenous opiate which can affect basal cortisol 
elevation and reduce the hormone Lutein Hormone (LH) which causes amenorrhea. 
CARING: Indonesian Journal of Nursing Science (IJNS) Vol. 1, No.1, 2019 | 36 – 48 39 
 
(8) The use of injectable contraception for more than 1 year is in accordance with the purpose of 
contraception, which is to space pregnancy and one of the advantages of DMPA injection 
contraception method is to prevent long-term pregnancy. DMPA injection contraceptive 
method, women can adjust the distance of pregnancy as desired with the duration of DMPA 
injection contraceptive use. the duration of use of DMPA injection contraception for ≤1 year 
and more than 1 year there is a menstrual disorder that is mostly amenorrhoea (Munayarokh, 
2014). 
2. Research Methods 
The design used in this study is descriptive which aims to determine the menstrual pattern in 
users of progestin and combination injection contraception in the western range sub-district, 
precisely in the Sendang Sari and Dadimulyo Sub-Districts totaling 348 people with a total 
sample of 76 people, data collection techniques used are accidental techniques sampling. 
3. Research Result 
Table 1. Frequency distribution and percentage of menstrual patterns of progestin and 
combination injectable contraceptive users 
Menstrual 
Pattern 
Progestin 
Injection 
Contraceptive 
 Combination 
Injection 
Contraceptive 
 
 f % f % 
Normal 6 15,8   9 23,7 
Abnormal 32 84,2 29 76,3 
 
Table 2.  Frequency and Percentage of Menstrual Cycle Distribution of Progestin and 
Combination Injections Users 
Menstrual Cycle Progestin 
Injection 
Contraceptive 
 Combination 
Injection 
Contraceptive 
 
 f % f % 
Normal (21-35) 15 39,5 20 52,6 
Tidak normal  
≥ (21-35) 
23 60,5 18 47,4 
 
Table 3. Frequency Distribution and Long Menstrual Percentage of Progestin Injections 
and Combination Users 
Menstrual 
Period 
Progestin 
Injection 
Contraceptive 
 Combination 
Injection 
Contraceptive 
 
 f % f % 
Normal (2-8) 16 42,1 23 60,5 
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Abnormal  
≥ (2-8) 
22 57,9 15 39,5 
 
Table 4. Frequency Distribution and Percentage of Menstrual Blood Counts in Progestin and 
Combination Injections 
Amount of 
Menstrual Blood 
Progestin 
Injection 
Contraceptive 
 Combination 
Injection 
Contraceptive 
 
 f % f % 
Normal 
(30-80 ml) 
  13 34,2 9 23,7 
Abnormal 
≥ (30-80 ml) 
 29 65,8 25 76,3 
 
Table 5. Distribution of Frequency and Percentage of Dysmenorrhoea Contraceptive 
Users in Progestin and Combination 
 
Menstrual Pain Progestin 
Injection 
Contraceptive 
 Combination 
Injection 
Contraceptive 
 
 f % f % 
Yes 3 7,9 9 23,7 
Not  35 92,1 29 76,3 
 
Then the results of the study on the duration of menstrual pain that was felt in the most 
progestin injection contraceptive users were 0 days, which did not reduce menstrual pain by 35 
people (92.1%) and the lowest 2 days ie 1 person (2.6%) while the results of the study regarding 
the longest period of menstrual pain that was felt by the users of combined injection 
contraception was 0 days, that is, there was no menstrual pain as many as 29 people (76.3%) 
and duration of  menstrual pain 1,2, 3, days which was 9 people (23,7%) (mean = 0.11, SD = 
0.388). 
Table 6. Frequency Distribution and Long Percentage of Menstrual Pain Contraception 
Injection Progestin and Combination Users 
Lama Nyeri 
Haid 
KB 
Suntikan  
Progestin 
 KB 
Suntikan 
Kombinasi 
 
 f % f % 
0 hari 35 92,1 29 76,3 
1 hari 
2 hari 
3 hari  
2 
1 
- 
5,3 
2,6 
- 
3 
3 
3 
7,9 
7,9 
7,9  
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4. Research Discussion 
4.1. Menstrual Patterns of Progestin and Combination Contraceptive Users 
The results of the study found 32 progestin injection contraception users (84.2%) 
experienced abnormal menstrual patterns while in combination injection injection users 
there were 29 people (76.3%) who experienced abnormal menstrual patterns. Menstrual 
patterns are menstrual cycle regularity, duration of menstruation or the length of 
menstruation and the amount of menstrual blood (Manuaba, 2007). Side effects that can 
be obtained from the use of contraceptives can affect menstrual patterns or menstruation 
so that sometimes someone is very considerate in using contraception. Disadvantages of 
using progestin and combination contraceptives are changes in menstrual patterns such 
as irregular, spotting or spooting bleeding, intermittent bleeding for up to ten days. 
(Mulyani, 2013). The mechanism of action for hormonal progestin injection 
contraception by suppressing the ovulation phase of a person, the ovulation phase is 
good depending on the level of estrogen in the circulation. When injecting progestin 
levels in the circulation it increases to suppress feedback from hypothalamic 
gonadotropin releasing factors. Then it will prevent pituitary secretion by inhibiting the 
surge of luteinizing hormone (LH) with the main task of blocking the ovulation phase 
(egg maturation). In normal circumstances, LH surge is the most important indicator of 
ovulation. LH surge causes rupture of the foliker. This ovulation disorder is due to the 
absence of gonadotropin / low, so that there is no stimulus to the ovary, no 
folliculogenesis, no secretion of estrogen, hypogonotdropin. Hipesterogen will provide 
clinical symptoms of amenorrhea or irregular menstrual disorders due to the absence of 
endometrial growth (Wirakusumah.F.et.al, 2010). While the use of combined hormonal 
injection contraception works through inhibition of feedback on the hypothalamus to 
suppress GnRH and plasma gonadotropin secretion, thus blocking ovulation by 
suppressing FSH secretion so as to suppress the release of estrogen which causes the 
maturation of follicles not optimal and the presence of progesterone which can suppress 
LH work to inhibit release of secondary oocytes from follicles which will inhibit a 
person's ovulation phase. But sometimes the use of combined injection contraception 
causes a person's normal menstrual pattern caused by a person's body reaction and 
hormonal mechanisms in a person's body (Hardisman, 2014). 
4.2. Menstrual Cycle Injecting Progestin and Combination Users 
Based on the results of research on menstrual cycles in progestin injectable 
contraceptive users there were abnormal ≥ 21-35 days as many as 23 people (60.5%) 
while combination injection users had normal 21-35 days as many as 20 people 
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(52.6%). Things that can be found in using progestin injection contraception are the 
presence of a menstrual cycle that is elongated or shortened. Side effects on progestin 
contraceptive use are very high due to the content found in progestin injection 
contraceptives, namely the hormone progesterone (Mulyani, 2013). In the use of 
hormonal progestin injection contraception there is a mechanism of action by 
suppressing the ovulation phase of a person, the ovulation phase is good depending on 
the level of estrogen in the circulation. The mechanism of action is to suppress the 
feedback work of hypothalamic gonadotropin releasing factors. Then it will prevent 
pituitary secretion by inhibiting the surge of luteinizing hormone (LH) with the main 
task of blocking the ovulation phase (egg maturation). Normally the LH surge is an 
important indicator in the occurrence of ovulation which causes the primary follicle to 
develop in the ovary which will become the follicle deaf, if the LH and FSH are pressed 
the working fusion is suppressed so that de graaf follicles do not ripen, so that 
endometrial growth is imperfect and affects and blocks someone's ovulation (Sukarni, 
2013). 
 
In combination contraceptive use is relatively normal and abnormal, this is caused by 
the presence of a combination of injectable contraceptives, namely the hormone 
estrogen and progesterone. Combined hormonal injection contraception works through 
inhibition of feedback on the hypothalamus to suppress GnRH and plasma gonadotropin 
secretion, thereby blocking ovulation by suppressing FSH secretion so that it suppresses 
estrogen release which causes non-optimal follicle maturation and progesterone content 
which can suppress LH work to inhibit oocyte release secondary to the follicle which 
will inhibit one's ovulation phase. This event will cause irregularity in one's menstrual 
cycle. A normal and regular menstrual cycle is characterized by ovulation. Then in the 
post ovulation period (secretion) the maturation of follicles that are not optimal will 
become the corpus luteum. The corpus luteum secretes the hormone progesterone and 
the hormone estrogen that is not optimal. In the use of combination endometrial 
injections of hormonal injections will be atrophy which will interfere with implantation, 
causing endometrium to stop the production of the hormone estrogen and progesterone. 
This condition will cause irregular menstruation (Purwoastuti et al, 2015). 
 
4.3. Duration of Menstrual Progestin Injections and Combination Users 
In the results of this study it was found that the majority of prolonged abnormal 
progestin injection contraceptives ≤ 2-8 days were 22 people (57.9%) whereas 23 to 8 
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(60.5%) were used for normal combination injection contraception users. In the use of 
progestin injection contraception has a long side effect of a person's menstruation can be 
elongated or shortened (Pinem, 2009). Basically a normal menstrual cycle will follow 
the number of bleeding days or normal menstrual periods with a range of 2-8 days. In 
the use of hormonal progestin injection contraception there is a mechanism of action by 
suppressing the ovulation phase of a person, the ovulation phase is good depending on 
the level of estrogen in the circulation. The mechanism of action is to suppress the 
feedback work of hypothalamic gonadotropin releasing factors. Then it will prevent 
pituitary secretion by inhibiting the surge of luteinizing hormone (LH) with the main 
task of blocking the ovulation phase (egg maturation). Normally the LH surge is an 
important indicator in the occurrence of ovulation which causes the primary follicle to 
develop in the ovary which will become the follicle deaf, if the LH and FSH are pressed 
the working fusion is suppressed so that de graaf follicles do not ripen, so that 
endometrial growth is imperfect and affects and blocks someone's ovulation. The corpus 
rubrum (red) is formed which will become the imperfect corpus luteum (yellow). The 
corpus luteum produces the hormone progesterone which will affect the endometrium 
which has a proliferation which will cause the glands to curl and secretion irregularly 
(Sukarni, 2013). In the research conducted by Setyaningrum (2008), during 
menstruation the respondents experienced menstrual shortening as many as 25 people 
and until no menstruation. 
 
In the use of injectable contraception the combination of the ingredients is estrogen 
which can regulate menstruation to be regular. Ovarian hormones to produce estrogen 
and progesterone which will ripen the egg so that menstruation occurs which releases 
the uterine wall (endometrium) accompanied by bleeding that occurs every month 
(Ellya, 2010). The reduced amount of blood coming out on hormonal contraceptive use 
will affect the duration of menstruation which is affected and changed (Baziad. A, 
2008). In combined normal and abnormal injection contraceptive use, this is caused by 
the presence of combined injectable contraceptives, namely the hormone estrogen and 
progesterone. Combined hormonal injection contraception works through inhibition of 
feedback on the hypothalamus to suppress GnRH and plasma gonadotropin secretion, 
thereby blocking ovulation by suppressing FSH secretion so that it suppresses estrogen 
release which causes non-optimal follicle maturation and progesterone content which 
can suppress LH work to inhibit oocyte release secondary to the follicle which will 
inhibit one's ovulation phase. This event will cause irregularity in one's menstrual cycle. 
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A normal and regular menstrual cycle is characterized by ovulation. Then in the post 
ovulation period (secretion) the maturation of follicles that are not optimal will become 
the corpus luteum. The corpus luteum secretes the hormone progesterone and the 
hormone estrogen that is not optimal. At the combined use of endometrial hormonal 
injections injections will be atrophy which will interfere with implantation, causing 
endometrium to stop the production of estrogen and progesterone hormones. This 
condition will cause menstruation which irregularly expends blood during menstruation 
is not perfect and irregular menstrual periods (Purwoastuti et al. , 2015). 
 
4.4. Amount of Menstrual Blood in Progestin Injections and Combination Users 
The results of this study are based on the amount of menstrual blood progestin injection 
contraceptive categorized as abnormal ≥ 30-80 ml per cycle, whereas in combination 
injection contraception users it is categorized as abnormal ≥ 30- 80 ml per cycle of 25 
people (65.8%). Accepters who use contraception for 3 months the amount of menstrual 
blood can be a little or a lot this is a side effect on the use of contraception (Mulyani, 
2013). Menstrual blood is arterial blood, with 25% of blood coming from a vein. This 
blood contains residual tissue, prostaglandin, and fibrinolysin to release clots, so that 
normal blood menstrual blood does not experience clots unless in excessive amounts, 
the amount of blood coming out can be affected by several factors, including 
endometrial thickness, treatment, diseases that accompany the use of contraception 
(Ganong, 2012). 
When the corpus luteum degenerates due to the absence of fertilization and implantation 
of the released ovum during the previous cycle, the levels of estrogen and progesterone 
in the fall are sharp. Because the final effects of progesterone and estrogen are preparing 
the endometrium for implantation and fertilized by sperm, there is a decrease in the 
hormones in the ovary which free prostaglandins which cause vasoconstriction of blood 
vessels in the endometrim. So that O2 distribution decreases causing endometrial death 
and damage to blood vessels then rinsing the endometrium into the uterine lumen. The 
uterine prostaglandin is a mild rhythmic contraction in the meometrium of the uterus. 
These contractions help to menstruate blood (Sherwood, 2014). 
In the use of hormonal progestin injection contraception there is a mechanism of action 
by suppressing the ovulation phase of a person, the ovulation phase is good depending 
on the level of estrogen in the circulation. The mechanism of action is to suppress the 
feedback work of hypothalamic gonadotropin releasing factors. Then it will prevent 
pituitary secretion by inhibiting the surge of luteinizing hormone (LH) with the main 
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task of blocking the ovulation phase (egg maturation). Normally the LH surge is an 
important indicator in the occurrence of ovulation which causes the primary follicle to 
develop in the ovary which will become the follicle deaf, if the LH and FSH are pressed 
the working fusion is suppressed so that de graaf follicles do not ripen, so that 
endometrial growth is imperfect and affects and blocks someone's ovulation. The corpus 
rubrum (red) is formed which will become the imperfect corpus luteum (yellow). The 
corpus luteum produces the hormone progesterone which will affect the endometrium 
which has a proliferation which will cause the glands to curl and secretion irregularly 
causing the blood to come out not optimal (Sukarni, 2013). 
 
Whereas in combination injection use of normal contraception is relatively normal and 
not normal, this is caused by the presence of combined contraceptive injections, namely 
the hormone estrogen and progesterone. Combined hormonal injection contraception 
works through inhibition of feedback on the hypothalamus to suppress GnRH and 
plasma gonadotropin secretion, thereby blocking ovulation by suppressing FSH 
secretion so that it suppresses estrogen release which causes non-optimal follicle 
maturation and progesterone content which can suppress LH work to inhibit oocyte 
release secondary to the follicle which will inhibit one's ovulation phase. This event will 
cause irregularity in one's menstrual cycle. A normal and regular menstrual cycle is 
characterized by ovulation. Then in the post ovulation period (secretion) the maturation 
of follicles that are not optimal will become the corpus luteum. The corpus luteum 
secretes the hormone progesterone and the hormone estrogen that is not optimal. At the 
combined use of endometrial hormonal injection will be atrophy which will interfere 
with implantation, causing endometrium to stop the production of estrogen and 
progesterone hormones. This condition will cause menstruation which irregularly 
expends blood during imperfect menstruation and irregular menstrual periods 
(Purwoastuti et al, 2015). 
 
4.5. Menstrual Disorders of Progestin Injections and Combination Contraception 
In this study, the majority of those who experienced menstrual disorders amenorrhoea 
were found in both progestin and combination injectable contraceptive users. In 
progestin injection contraception users there were 20 people (52.6%) and combined 
injections of 13 people (34.2%). There are a number of different menstrual disorders 
from the menstrual cycle, length of menstruation and the amount of menstrual blood and 
whether there are ovulation problems or medical conditions (Begum.M, 2016). 
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According to Manuaba. S. etAl (2009), menstrual disorders or menstruation is a 
combination of genetalia health and complex hormonal stimuli that originate from the 
hypothalamic, hypophysis and ovarian axis. Therefore, menstrual disorders can occur 
from abnormalities of these two factors. Based on the results of a study conducted by 
Manur (2007), injectable contraceptive users 1 month and 3 months experienced 
amenorrhea in 145 people (75.23%). 
 
Then the results of this study found menstrual dysmenorrhoea disorders as many as 3 
people (7.9%) in progetsin hormonal injection contraceptive users and 9 people (23.7%) 
in combination hormonal injection contraceptive users. Dysmenorrhea is a subjective 
symptom due to increased hormone levels and contractions of the uterine muscles 
caused by prostaglandin. Before menstruation has increased and once menstruation has 
decreased prostaglandin levels, this can explain tend to decrease pain after the first few 
days of menstruation (Proverawati.A, 2009). 
 
In this study, the duration of dysmenorrhea in the use of hormonal progestin injection 
contraception was 1 day (2.6%) while in combination with 3 days of hormonal injection 
contraception, 3 people (7.9%). Menstrual pain that is felt is usually one or two days 
before menstruation comes and at the first day the nature of the pain starts from mild to 
severe which lasts for 12 to 72 hours the longest (Putra, 2015). 
5. Conclusions 
In progestin injection contraceptive users and combinations there are abnormal menstrual 
patterns. So that the practice of maternity nursing can consider the provision of appropriate 
contraceptives for mothers who want to place pregnancies using injectable contraceptives that 
have side effects of use, namely the occurrence of irregular menstrual patterns so that KB 
counselors provide counseling or consultation in advance to notify what is the working 
mechanism of 1 month and 3 months injection contraception which results in one of the regular 
menstrual patterns becoming irregular. 
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